This Special Report discusses the management of OIC in patients with advanced illness, including RELISTOR (methylnaltrexone bromide), a second-line therapeutic option that inhibits opioids from binding to target receptors within the GI tract and does not cross the blood-brain barrier.
via Pain Medicine News – Management of Opioid-Induced Constipation in Patients With Advanced Illness.